ACCESSION: MSBNK-SMB_Measured-HSA015P0111012
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.03.05 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.05, Curated 2025.03.05)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 61
COMMENT: RAW_SPEC {'EL05_pos_2647': {'bp': 1241327.0, 'sum': 2217029.0}, 'EL05_pos_1913': {'bp': 167463.0, 'sum': 654565.0}, 'EL02_pos_2633': {'bp': 523390.0, 'sum': 1190520.0}, 'EL19_pos_2506': {'bp': 461604.0, 'sum': 1098047.0}, 'EL22_pos_2651': {'bp': 859204.0, 'sum': 1682128.0}, 'EL07_pos_1912': {'bp': 133255.0, 'sum': 529323.0}, 'EL19_pos_2659': {'bp': 985260.0, 'sum': 1851214.0}, 'EL20_pos_2476': {'bp': 433210.0, 'sum': 1001386.0}, 'EL06_pos_1929': {'bp': 173217.0, 'sum': 611915.0}, 'EL17_pos_2633': {'bp': 1011333.0, 'sum': 1872355.0}, 'EL06_pos_2638': {'bp': 732461.0, 'sum': 1420175.0}, 'EL20_pos_2626': {'bp': 487421.0, 'sum': 1076448.0}, 'EL03_pos_2864': {'bp': 709257.0, 'sum': 1605805.0}, 'EL23_pos_2644': {'bp': 517921.0, 'sum': 1091333.0}, 'EL06_pos_2489': {'bp': 466516.0, 'sum': 1040062.0}, 'EL02_pos_2471': {'bp': 312397.0, 'sum': 917961.0}, 'EL09_pos_1918': {'bp': 163786.0, 'sum': 604704.0}, 'EL24_pos_2546': {'bp': 1151889.0, 'sum': 1938567.0}, 'EL22_pos_2494': {'bp': 439312.0, 'sum': 1096620.0}, 'EL12_pos_2615': {'bp': 420619.0, 'sum': 928138.0}, 'EL21_pos_2626': {'bp': 394692.0, 'sum': 907354.0}, 'EL08_pos_2642': {'bp': 982416.0, 'sum': 1773758.0}, 'EL10_pos_2488': {'bp': 454103.0, 'sum': 981855.0}, 'EL21_pos_2477': {'bp': 415264.0, 'sum': 963627.0}, 'EL21_pos_1913': {'bp': 146288.0, 'sum': 560868.0}, 'EL18_pos_2641': {'bp': 765013.0, 'sum': 1495665.0}, 'EL17_pos_2481': {'bp': 682494.0, 'sum': 1388228.0}, 'EL15_pos_2464': {'bp': 547454.0, 'sum': 1170801.0}, 'EL07_pos_2522': {'bp': 160086.0, 'sum': 511932.0}, 'EL09_pos_2620': {'bp': 498930.0, 'sum': 1069584.0}, 'EL03_pos_2746': {'bp': 460534.0, 'sum': 1280010.0}, 'EL12_pos_2458': {'bp': 426766.0, 'sum': 982777.0}, 'EL17_pos_1907': {'bp': 188803.0, 'sum': 632336.0}, 'EL20_pos_1917': {'bp': 171379.0, 'sum': 575590.0}, 'EL04_pos_2671': {'bp': 1185578.0, 'sum': 2040558.0}, 'EL16_pos_2627': {'bp': 1166667.0, 'sum': 2051419.0}, 'EL01_pos_2639': {'bp': 712700.0, 'sum': 1391269.0}, 'EL18_pos_2489': {'bp': 516787.0, 'sum': 1142598.0}, 'EL09_pos_2463': {'bp': 431046.0, 'sum': 985375.0}, 'EL16_pos_1905': {'bp': 149567.0, 'sum': 551172.0}, 'EL18_pos_1913': {'bp': 143965.0, 'sum': 533586.0}, 'EL14_pos_2633': {'bp': 1004117.0, 'sum': 1824369.0}, 'EL07_pos_2636': {'bp': 792555.0, 'sum': 1493225.0}, 'EL24_pos_2678': {'bp': 754676.0, 'sum': 1430455.0}, 'EL10_pos_1918': {'bp': 156026.0, 'sum': 576790.0}, 'EL10_pos_2641': {'bp': 882368.0, 'sum': 1603103.0}, 'EL11_pos_2619': {'bp': 509528.0, 'sum': 1061914.0}, 'EL15_pos_2621': {'bp': 503944.0, 'sum': 1055935.0}, 'EL08_pos_1918': {'bp': 172885.0, 'sum': 575951.0}, 'EL13_pos_2639': {'bp': 826235.0, 'sum': 1548919.0}, 'EL14_pos_2470': {'bp': 423915.0, 'sum': 978625.0}, 'EL23_pos_2493': {'bp': 289617.0, 'sum': 787245.0}, 'EL15_pos_1919': {'bp': 169877.0, 'sum': 617187.0}, 'EL05_pos_2528': {'bp': 154319.0, 'sum': 578040.0}, 'EL04_pos_2557': {'bp': 132687.0, 'sum': 494409.0}, 'EL16_pos_2469': {'bp': 685952.0, 'sum': 1351478.0}, 'EL13_pos_2482': {'bp': 312537.0, 'sum': 837688.0}, 'EL01_pos_2522': {'bp': 238683.0, 'sum': 620528.0}, 'EL08_pos_2527': {'bp': 203406.0, 'sum': 591725.0}, 'EL13_pos_1919': {'bp': 161607.0, 'sum': 549211.0}, 'EL11_pos_2463': {'bp': 517332.0, 'sum': 1060051.0}}
COMMENT: RETENTION_TIME_STDEV 0.458
COMMENT: PRECURSOR_M/Z_RAW 111.092117
COMMENT: PRECURSOR_M/Z_STDEV 0.000034
COMMENT: PRECURSOR_IN_MS1 mz 111.091680; int 113.618; delta(ppm) 0.694547
COMMENT: PROPOSED_CHARGE_STATE +1; mz 112.094988; int 7.943; cor 0.900
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+IsoProp+H; M+CH3OH+H; mz 83.060363; int 6.984; cor 0.642
COMMENT: PROPOSED_ION_FORM M+IsoProp+H; M+2ACN+H; mz 133.085920; int 23.249; cor 0.640
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.027; C6H10N2; [M+H]+; delta(ppm) 0.027252
COMMENT: PROPOSED_MF MS-FINDER 3.126; C6H10N2; [M+H]+; delta(ppm) 0.020112
COMMENT: PROPOSED_MF SIRIUS5_Sirius 29.820; C6H10N2; [M+H]+; delta(ppm) 0.020112
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H10N2; [M+H]+; delta(ppm) 0.020112
COMMENT: PROPOSED_MF SIRIUS6_Sirius 39.307; C6H10N2; [M+H]+; delta(ppm) 0.020112
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H10N2; [M+H]+; delta(ppm) 0.020112
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.000; JOHCCHGNXMXHPU-UHFFFAOYSA-N; [M+H]+; N1=NC2CCC1CC2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.589; ULKLGIFJWFIQFF-UHFFFAOYSA-N; [M+H]+; CCC1=NC=C(C)N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.254; QBNRQCHCKIIYGV-UHFFFAOYSA-N; [M+H]+; CCCC1=CC=NN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; BWOLKJCEPCQYDO-UHFFFAOYSA-N; [M+H]+; N[C]1[CH][CH][C]([CH][NH2+]1)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; DWRXYYUVHHNTHL-UHFFFAOYSA-N; [M+H]+; N[C]1[C]([CH][CH][CH][NH2+]1)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.946; JOHCCHGNXMXHPU-UHFFFAOYSA-N; [M+H]+; 2,3-diazabicyclo[2.2.2]oct-2-ene
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.780; QBNRQCHCKIIYGV-UHFFFAOYSA-N; [M+H]+; 5-propyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.780; VTNUQSAAFBRENH-UHFFFAOYSA-N; [M+H]+; 1,2-dimethyl-1??-pyrazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.752; ULKLGIFJWFIQFF-UHFFFAOYSA-N; [M+H]+; 2-ethyl-4-methylimidazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.706; BWOLKJCEPCQYDO-UHFFFAOYSA-N; [M+H]+; 2-amino-5-methylpiperidin-1-ium-4-yl
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.706; DWRXYYUVHHNTHL-UHFFFAOYSA-N; [M+H]+; 2-amino-3-methylpiperidin-1-ium-4-yl
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.706; PBDKIJOORUPHJN-UHFFFAOYSA-N; [M+H]+; 2-amino-4-methylpiperidin-1-ium-3-yl
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; QBNRQCHCKIIYGV-UHFFFAOYSA-N; [M+H]+; 5-propyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.996; ULKLGIFJWFIQFF-UHFFFAOYSA-N; [M+H]+; 2-ethyl-4-methylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.977; BWOLKJCEPCQYDO-UHFFFAOYSA-N; [M+H]+; 2-amino-5-methylpiperidin-1-ium-4-yl
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.967; PBDKIJOORUPHJN-UHFFFAOYSA-N; [M+H]+; 2-amino-4-methylpiperidin-1-ium-3-yl
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.963; DWRXYYUVHHNTHL-UHFFFAOYSA-N; [M+H]+; 2-amino-3-methylpiperidin-1-ium-4-yl
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.810; JOHCCHGNXMXHPU-UHFFFAOYSA-N; [M+H]+; 2,3-diazabicyclo[2.2.2]oct-2-ene
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.916; ULKLGIFJWFIQFF-UHFFFAOYSA-N; [M+H]+; 2-ethyl-5-methyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.559; QBNRQCHCKIIYGV-UHFFFAOYSA-N; [M+H]+; 5-propyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.655; KMBJEVSXNIUPIH-UHFFFAOYSA-N; [M+H]+; 3-(aziridin-1-yl)butanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.648; FUOZJYASZOSONT-UHFFFAOYSA-N; [M+H]+; 2-propan-2-yl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.632; MKBBSFGKFMQPPC-UHFFFAOYSA-N; [M+H]+; 2-propyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.553; NPRYXVXVLCYBNS-UHFFFAOYSA-N; [M+H]+; 2-pyrrolidin-1-ylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.532; IPIORGCOGQZEHO-UHFFFAOYSA-N; [M+H]+; 1-propan-2-ylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.524; YAVXLTMRALFZIS-UHFFFAOYSA-N; [M+H]+; piperidine-2-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.334; JTAPOORUPPEREW-UHFFFAOYSA-N; [M+H]+; 1-(methylamino)cyclobutane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.333; UMMIQMAIGBATCS-UHFFFAOYSA-N; [M+H]+; 2-(cyclopropylamino)propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.315; IYVYLVCVXXCYRI-UHFFFAOYSA-N; [M+H]+; 1-propylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.314; FVPYQTSLDMVWBM-UHFFFAOYSA-N; [M+H]+; 3-methylpyrrolidine-3-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.314; VDSAXHBDVIUOGV-UHFFFAOYSA-N; [M+H]+; 1-ethenyl-2-methyl-4,5-dihydroimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.309; VGFGZZVMDIZSTI-UHFFFAOYSA-N; [M+H]+; 2-amino-2-cyclopropylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.275; LZECJKUQMLXNBD-UHFFFAOYSA-N; [M+H]+; 1-amino-2,2-dimethylcyclopropane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.256; BDMFEFZOOOYCKN-UHFFFAOYSA-N; [M+H]+; 1-propylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.251; NYYVCPHBKQYINK-UHFFFAOYSA-N; [M+H]+; 1-ethyl-2-methylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.251; FSDNTQSJGHSJBG-UHFFFAOYSA-N; [M+H]+; piperidine-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.242; ZAXITHHHFYZUGN-UHFFFAOYSA-N; [M+H]+; 3-ethyl-1-methylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.242; NVPICXQHSYQKGM-UHFFFAOYSA-N; [M+H]+; piperidine-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.238; HNOQAFMOBRWDKQ-UHFFFAOYSA-N; [M+H]+; 1,3,5-trimethylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.234; YAXKXMVDJJMGRY-UHFFFAOYSA-N; [M+H]+; 4-propyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.218; ANMVTDVBEDVFRB-UHFFFAOYSA-N; [M+H]+; 1-propan-2-ylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.202; OZHWHTICSNFGBZ-UHFFFAOYSA-N; [M+H]+; 3-(cyclopropylamino)propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.201; ZICRALLMHKILDG-UHFFFAOYSA-N; [M+H]+; 5-propan-2-yl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.197; ZGNXATVKGIJQGC-UHFFFAOYSA-N; [M+H]+; piperidine-3-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.192; WVMBISZHWMJNNM-UHFFFAOYSA-N; [M+H]+; 4-propan-2-yl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.188; ZKKCALAGXBADEJ-UHFFFAOYSA-N; [M+H]+; 2-pyrrolidin-3-ylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.184; HUVAAOZUPLEYBH-UHFFFAOYSA-N; [M+H]+; 3,4,5-trimethyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.182; KFPMRYNOEZCHDP-UHFFFAOYSA-N; [M+H]+; 1-aminocyclopentane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.174; HINMGNHBDCADKG-UHFFFAOYSA-N; [M+H]+; 5-propan-2-yl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.172; HERJCJRIDHRCKG-UHFFFAOYSA-N; [M+H]+; 2-aminocyclopentane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.172; PKTNSCWXNMMDQK-UHFFFAOYSA-N; [M+H]+; 3-aminocyclopentane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.167; UEBWHAAQVVWZAU-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)cyclobutane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.166; SFEKRFLQOGMHSZ-UHFFFAOYSA-N; [M+H]+; 2-[1-(aminomethyl)cyclopropyl]acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.161; PTBPTNCGZUOCBK-UHFFFAOYSA-N; [M+H]+; 2,4,5-trimethyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.146; GGCBARJYVAPZJQ-UHFFFAOYSA-N; [M+H]+; (1-methylpyrrol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.142; ZAOLDHBNVDOBDU-UHFFFAOYSA-N; [M+H]+; (1-methylpyrrol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.139; NALRGBZDHLOOTD-UHFFFAOYSA-N; [M+H]+; 2,5-dimethylpyrrol-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.130; KYCDNQPIQHCAFW-UHFFFAOYSA-N; [M+H]+; 1-(1H-pyrrol-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; RFBQAWJJJXBCSN-UHFFFAOYSA-N; [M+H]+; 1-(1H-pyrrol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.042; ZOORJGVSPXCZCJ-UHFFFAOYSA-N; [M+H]+; N,N-dimethylpyrrol-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; MRGFCRUGPMFUHD-UHFFFAOYSA-N; [M+H]+; 3-(aminomethyl)cyclobutane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; YBTQATWVNNDUDN-UHFFFAOYSA-N; [M+H]+; 2-(3-aminocyclobutyl)acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.909; IAZZNTYMXXEHHT-UHFFFAOYSA-N; [M+H]+; 2-(1H-pyrrol-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.901; ZBJSHMBQYSDTGK-UHFFFAOYSA-N; [M+H]+; 2-(1H-pyrrol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.897; HPDIRFBJYSOVKW-UHFFFAOYSA-N; [M+H]+; 2-pyrrol-1-ylethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -66.365; MBAJKEJMOVVLRP; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -95.673; NVPICXQHSYQKGM; [M+H]+; 1-Cyanopiperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -97.948; NPRYXVXVLCYBNS; [M+H]+; Pyrrolidinoacetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -109.137; IYVYLVCVXXCYRI; [M+H]+; propylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -109.535; NYYVCPHBKQYINK; [M+H]+; 1-ethyl-2-methylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -111.059; IPIORGCOGQZEHO; [M+H]+; 1-Isopropylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -115.770; JOHCCHGNXMXHPU; [M+H]+; 2,3-Diazabicyclo(2.2.2)oct-2-ene
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -117.074; NJMWOUFKYKNWDW; [M+H]+; Meetimcl
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -122.976; APYDCJBHJXFOTJ; [M+H]+; 2,3-Dihydro-5,6-dimethylpyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -144.646; VDSAXHBDVIUOGV; [M+H]+; 1-ethenyl-2-methyl-4,5-dihydroimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -148.253; WLWHLUQQCLCFNE; [M+H]+; 1-ethenyl-3-methyl-2H-imidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -148.882; ZGNXATVKGIJQGC; [M+H]+; 3-cyanopiperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -149.344; FUOZJYASZOSONT; [M+H]+; 2-Isopropylimdazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -153.820; FSDNTQSJGHSJBG; [M+H]+; ACMC-20aipl
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -156.563; OZHWHTICSNFGBZ; [M+H]+; ACMC-20ankz
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -161.202; MKBBSFGKFMQPPC; [M+H]+; zlchem 316
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -161.448; KMBJEVSXNIUPIH; [M+H]+; 3-(1-Aziridinyl)butyronitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -165.223; HPDIRFBJYSOVKW; [M+H]+; pyrrolylethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -168.502; BDMFEFZOOOYCKN; [M+H]+; propylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -168.575; ANMVTDVBEDVFRB; [M+H]+; 1-propan-2-ylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -169.834; ULKLGIFJWFIQFF; [M+H]+; Imidazole C-2 deriv. 2
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -181.572; KFPMRYNOEZCHDP; [M+H]+; Ambcb4035549
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -183.180; HINMGNHBDCADKG; [M+H]+; 5-propan-2-yl-1H-imidazol-3-ium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -191.329; PKTNSCWXNMMDQK; [M+H]+; 3-Aminocyclopentanecarbonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -192.704; GGCBARJYVAPZJQ; [M+H]+; (1-methylpyrrol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -194.462; ZOORJGVSPXCZCJ; [M+H]+; 1-(Dimethylamino)pyrrole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -208.415; HNOQAFMOBRWDKQ; [M+H]+; Pyrazole, 1,3,5-trimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -209.843; NJIDBKRVRJXCLL; [M+H]+; 1-methyl-2H-pyridin-5-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -211.316; ZICRALLMHKILDG; [M+H]+; zlchem 589
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -211.425; QBNRQCHCKIIYGV; [M+H]+; 3-Propylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -217.869; PTBPTNCGZUOCBK; [M+H]+; 2,4,5-Trimethylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -236.885; HUVAAOZUPLEYBH; [M+H]+; 3,4,5-Trimethylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.466; MBAJKEJMOVVLRP; [M+H]+; nan
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C6H11N2; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 3.930
MS$FOCUSED_ION: PRECURSOR_M/Z 111.091677
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-4900000000-9078583567db734d7f84
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  53.0388621 11.5776 53.039560 1.1124 9.10 -0.3128 45 f{C4H5}/5.38ppm,p-C2H6N2
  55.0180624 15.9811 55.018770 1.1269 11.77 -0.1394 59 ?
  55.0545122 61.3916 55.055220 0.5994 45.94 -0.3264 61 f{C4H7}/5.19ppm,p-C2H4N2
  56.0497078 14.1849 56.050420 1.0170 5.66 0.7210 59 f{C3H6N1}/4.14ppm,p-C3H5N1
  65.0387211 18.6482 65.039460 0.9072 14.00 -0.2973 59 f{C5H5}/2.22ppm,p-C1H6N2
  67.0544085 85.1590 67.055150 0.5816 61.58 -0.2326 61 f{C5H7}/2.71ppm,p-C1H4N2
  68.0496176 24.7892 68.050360 1.0140 18.27 0.1380 61 f{C4H6N1}/2.09ppm,p-C2H5N1
  69.0336770 46.9005 69.034420 0.9271 34.20 -0.2019 56 ?
  69.0699770 24.6897 69.070720 0.6370 17.98 -0.3528 49 f{C5H9}/1.45ppm,p-C1H2N2
  70.0652567 120.2397 70.066000 0.6137 106.85 -0.3608 61 f{C4H8N1}/1.87ppm,p-C2H3N1
  70.9419218 33.2668 70.942665 0.9444 20.76 0.3462 60 ?
  71.9403371 9.1349 71.941080 0.8201 6.11 0.3538 43 ?
  79.0542778 11.8995 79.055010 1.3409 9.32 -0.1532 51 f{C6H7}/0.65ppm,p-H4N2
  81.0699336 22.1912 81.070660 0.9251 18.16 -0.4516 58 f{C6H9}/0.70ppm,p-H2N2
  82.0651769 14.6193 82.065900 1.1211 9.25 0.2305 57 f{C5H8N1}/0.62ppm,p-C1H3N1
  83.0492105 19.0288 83.049930 1.0717 16.46 -0.3939 53 ?
  83.0604255 34.2909 83.061145 1.0474 18.10 0.8168 54 f{C4H7N2}/0.61ppm,p-C2H4
  83.0855506 26.8084 83.086270 1.0351 19.87 -0.1964 61 f{C6H11}/0.29ppm,p-N2
  84.0808445 44.2911 84.081560 0.7374 17.60 0.6892 61 f{C5H10N1}/0.82ppm,p-C1H1N1
  86.9927477 17.5158 86.993450 1.1610 17.92 -0.4926 48 ?
  93.0698733 12.1642 93.070540 1.2356 8.57 -0.0167 52 ?
  94.0651702 24.4798 94.065830 1.2226 19.81 -0.0563 59 f{C6H8N1}/0.47ppm,p-H3N1
  96.0682050 77.8978 96.068850 1.0097 65.11 0.6713 57 f{C5H8N2}/0.06ppm,p-C1H3
  105.0032955 20.3271 105.003860 1.3428 20.59 -0.7225 46 ?
  109.0760712 11.7686 109.076600 1.1735 7.04 0.4987 44 f{C6H9N2}/0.43ppm,p-H2
  109.1012214 18.4422 109.101750 1.2465 14.67 -0.2868 59 ?
  110.0600882 55.8072 110.060610 0.7269 35.51 0.5530 61 ?
  111.0441654 29.2487 111.044680 1.0266 24.43 -0.5018 53 ?
  111.0554055 57.0918 111.055920 1.0625 42.38 0.0971 44 ?
  111.0917357 999.0000 111.092250 0.2971 0.00 1.0000 61 f{C6H11N2}/0.55ppm,p
  112.0392979 15.2588 112.039805 1.1692 11.15 0.0276 54 ?
  112.0758032 67.6608 112.076310 0.6513 52.49 0.0752 59 ?
  112.0950533 67.3536 112.095560 0.6512 5.78 0.9878 59 ?
  112.1119934 22.6844 112.112500 1.1150 18.16 -0.5526 52 ?
  113.0597308 43.6163 113.060230 1.1498 31.19 -0.1803 60 ?
PK$NUM_PEAK: 35
PK$PEAK: m/z int. rel.int.
  53.038862 11.58 11
  55.018062 15.98 15
  55.054512 61.39 61
  56.049708 14.18 14
  65.038721 18.65 18
  67.054408 85.16 85
  68.049618 24.79 24
  69.033677 46.90 46
  69.069977 24.69 24
  70.065257 120.24 120
  70.941922 33.27 33
  71.940337 9.13 9
  79.054278 11.90 11
  81.069934 22.19 22
  82.065177 14.62 14
  83.049210 19.03 19
  83.060426 34.29 34
  83.085551 26.81 26
  84.080845 44.29 44
  86.992748 17.52 17
  93.069873 12.16 12
  94.065170 24.48 24
  96.068205 77.90 77
  105.003295 20.33 20
  109.076071 11.77 11
  109.101221 18.44 18
  110.060088 55.81 55
  111.044165 29.25 29
  111.055405 57.09 57
  111.091736 999.00 999
  112.039298 15.26 15
  112.075803 67.66 67
  112.095053 67.35 67
  112.111993 22.68 22
  113.059731 43.62 43
//
